VentriPoint Diagnostics (CVE:VPT) Trading Down 14.7% – Here’s Why

by · The Markets Daily

VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) fell 14.7% during mid-day trading on Tuesday . The stock traded as low as C$0.15 and last traded at C$0.15. 266,015 shares were traded during mid-day trading, a decline of 10% from the average session volume of 294,436 shares. The stock had previously closed at C$0.17.

VentriPoint Diagnostics Stock Down 14.7 %

The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The firm has a market capitalization of C$23.52 million, a PE ratio of -4.48 and a beta of 0.39. The company’s 50 day simple moving average is C$0.10 and its 200-day simple moving average is C$0.13.

VentriPoint Diagnostics Company Profile

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.

Featured Stories